Indicator | Comparison A comparison between a company and a defined peer group. Learn More ↗ Opens in a New Tab | Rank |
|---|---|---|
Revenue | 1,117 € | 7 / 7-0.1% |
Net Profit | -6,131 € | 4 / 7-143.9% |
Assets | 22,219 € | 5 / 7-21.8% |
Equity | 22,153 € | 4 / 6-21.7% |
Company Age | 30 years · | 1 / 11 |
Net profit as a share of revenue.
Equity as a share of total assets.
Indicator | 2025Latest | 2024 | 2023 |
|---|---|---|---|
Revenue | 1,117 € -0.1% | 1,118 € | 1,311 € |
Net Profit | -6,131 € -143.9% | -2,514 € | 6,430 € |
Assets | 22,219 € -21.8% | 28,417 € | 30,845 € |
LiabilitiesAmounts a company owes to lenders, suppliers, and other creditors. Learn More ↗ Opens in a New Tab | 66 € -50.4% | 133 € | 47 € |
Equity | 22,153 € -21.7% | 28,284 € | 30,798 € |
EmployeesThe reported number of employees for the accounting period. Learn More ↗ Opens in a New Tab | 0 | 0 | 0 |
Industry | Code | Share | Revenue |
|---|---|---|---|
Manufacture of Pharmaceutical Preparations | 21.20 | 100.0% | 1,117 € |
Country | Share | Revenue |
|---|---|---|
Estonia | 100.0% | 1,117 € |
Name | Born | Roles A registered connection between a person or organisation and a company. Learn More ↗ Opens in a New Tab | |
|---|---|---|---|
- | Board Member · Shareholder 99.70% · Beneficial Owner | ||
Shareholder ~0.3% |
Name | Born | Nationality | Registered | |
|---|---|---|---|---|
- | - |
Name | Born | Position | Registered | |
|---|---|---|---|---|
- |
Name | Born | Roles | Until |
|---|---|---|---|
- | Board Member · Shareholder 99.70% · Beneficial Owner |
In 2025: revenue 1.1 thousand €, loss 6.1 thousand €, no employees. Share capital 6,391 €. Beneficial owner: Rein Ebenek.